Uncategorised
New Guidelines for Thyroid Eye Disease
It is estimated that there are about 2,500 new cases of Thyroid Eye Disease (TED) every year in the UK. The figures have declined over the past 10-20 years for reasons that are unclear. Nonetheless, far too often TED is undiagnosed for several months, or misdiagnosed as allergy or conjunctivitis, adding to the frustration of
Response to NICE announcing final guidance for Ozurdex® for the treatment of visual impairment due to diabetic macular oedema (DMO)
The Royal College of Ophthalmologists welcomes the Final Appraisal Determination (FAD) from NICE recommending Ozurdex® (dexamethasone intravitreal implant) as a clinically and cost effective treatment option for selected patients with visual impairment due to diabetic macular oedema (DMO). In the final guidance, dexamethasone intravitreal implant is recommended as a treatment option in people if: the
Starting Point: a guide for parents of children with visual impairment
The RCOphth Paediatric Sub-committee would like to draw attention to the information booklet “Starting Point” that has been produced by the RNIB and Blind Children UK. This provides useful and important information for patients and parents of children with visual impairment. Ophthalmologists should also be aware of the availability from the Blind Children UK’s website of other
SAS National Eye Day 2015
Start: 16th October 2015 Type: SAS Annual Meeting Description: Highlights include: 1. Uveitis Update – Miss Narciss Okhravi 2. Staying Friends with the GMC 3. Corneal Disease and Keratoconus Update – Stephen Kaye 4. The Patient Experience 5. Clinical Pearls For more information and to book a place click here:
Our Strategic Plan 2015 – 19
The Royal College of Ophthalmologists launched their Strategic Plan 2015 – 19 on 6 March 2015. The Plan was developed after broad consultation and outlines three priority areas over the next five years that the College will focus on to help shape eye care services of the future and to raise eye care higher on the